211 related articles for article (PubMed ID: 10867786)
21. Capacity for financial decision making in multiple sclerosis.
Tracy VL; Basso MR; Marson DC; Combs DR; Whiteside DM
J Clin Exp Neuropsychol; 2017 Feb; 39(1):46-57. PubMed ID: 27430343
[TBL] [Abstract][Full Text] [Related]
22. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
[TBL] [Abstract][Full Text] [Related]
23. Structured assessment of mental capacity to make financial decisions in Chinese older persons with mild cognitive impairment and mild Alzheimer disease.
Lui VW; Lam LC; Chau RC; Fung AW; Wong BM; Leung GT; Leung KF; Chiu HF; Karlawish JH; Appelbaum PS
J Geriatr Psychiatry Neurol; 2013 Jun; 26(2):69-77. PubMed ID: 23504307
[TBL] [Abstract][Full Text] [Related]
24. Awareness of deficits in financial abilities in patients with mild cognitive impairment: going beyond self-informant discrepancy.
Okonkwo OC; Wadley VG; Griffith HR; Belue K; Lanza S; Zamrini EY; Harrell LE; Brockington JC; Clark D; Raman R; Marson DC
Am J Geriatr Psychiatry; 2008 Aug; 16(8):650-9. PubMed ID: 18669943
[TBL] [Abstract][Full Text] [Related]
25. Nonepisodic memory deficits in amnestic MCI.
Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
[TBL] [Abstract][Full Text] [Related]
26. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
27. Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease.
Dymek MP; Atchison P; Harrell L; Marson DC
Neurology; 2001 Jan; 56(1):17-24. PubMed ID: 11148230
[TBL] [Abstract][Full Text] [Related]
28. Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects.
Weiss EM; Kohler CG; Vonbank J; Stadelmann E; Kemmler G; Hinterhuber H; Marksteiner J
Am J Geriatr Psychiatry; 2008 Dec; 16(12):974-80. PubMed ID: 19038896
[TBL] [Abstract][Full Text] [Related]
29. Cognitive Performance Test: a new approach to functional assessment in Alzheimer's disease.
Burns T; Mortimer JA; Merchak P
J Geriatr Psychiatry Neurol; 1994; 7(1):46-54. PubMed ID: 8192830
[TBL] [Abstract][Full Text] [Related]
30. Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline.
Binetti G; Locascio JJ; Corkin S; Vonsattel JP; Growdon JH
Arch Neurol; 2000 Feb; 57(2):225-32. PubMed ID: 10681082
[TBL] [Abstract][Full Text] [Related]
31. ADCS Prevention Instrument Project: overview and initial results.
Ferris SH; Aisen PS; Cummings J; Galasko D; Salmon DP; Schneider L; Sano M; Whitehouse PJ; Edland S; Thal LJ;
Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S109-23. PubMed ID: 17135805
[TBL] [Abstract][Full Text] [Related]
32. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.
Palmer BW; Dunn LB; Appelbaum PS; Mudaliar S; Thal L; Henry R; Golshan S; Jeste DV
Arch Gen Psychiatry; 2005 Jul; 62(7):726-33. PubMed ID: 15997013
[TBL] [Abstract][Full Text] [Related]
33. Cognitive models that predict physician judgments of capacity to consent in mild Alzheimer's disease.
Marson DC; Hawkins L; McInturff B; Harrell LE
J Am Geriatr Soc; 1997 Apr; 45(4):458-64. PubMed ID: 9100715
[TBL] [Abstract][Full Text] [Related]
34. The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline.
Vliet EC; Manly J; Tang MX; Marder K; Bell K; Stern Y
J Int Neuropsychol Soc; 2003 Jul; 9(5):720-32. PubMed ID: 12901778
[TBL] [Abstract][Full Text] [Related]
35. Mild Alzheimer Disease, Financial Capacity, and the Role of Depression: Eyes Wide Shut?
Giannouli V; Tsolaki M
Alzheimer Dis Assoc Disord; 2021 Oct-Dec 01; 35(4):360-362. PubMed ID: 33443873
[TBL] [Abstract][Full Text] [Related]
36. Psychometric characteristics of the Rivermead Behavioural Memory Test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil.
Yassuda MS; Flaks MK; Viola LF; Pereira FS; Memória CM; Nunes PV; Forlenza OV
Int Psychogeriatr; 2010 Sep; 22(6):1003-11. PubMed ID: 20598195
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the Financial Capacity in the Context of Normal and Pathological Cognitive Aging. Preliminary Analysis of the Portuguese Version of the
Sousa L; Baptista N; Gomes C; Peixoto M; Baeta É; Rocha JC; Lopes E; Peixoto B
Exp Aging Res; 2022; 48(3):261-273. PubMed ID: 34542026
[TBL] [Abstract][Full Text] [Related]
38. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment.
Karlawish JH; Casarett DJ; James BD; Xie SX; Kim SY
Neurology; 2005 May; 64(9):1514-9. PubMed ID: 15883310
[TBL] [Abstract][Full Text] [Related]
39. Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards.
Marson DC; Chatterjee A; Ingram KK; Harrell LE
Neurology; 1996 Mar; 46(3):666-72. PubMed ID: 8618664
[TBL] [Abstract][Full Text] [Related]
40. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population.
Reid W; Broe G; Creasey H; Grayson D; McCusker E; Bennett H; Longley W; Sulway MR
Arch Neurol; 1996 Oct; 53(10):1056-61. PubMed ID: 8859068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
